# ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

> **NCT00355108** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 170 (actual)

## Conditions studied

- Telangiectasia, Hereditary Hemorrhagic
- Osler-Rendu Disease

## Interventions

- **DRUG:** tranexamic acid

## Key facts

- **NCT ID:** NCT00355108
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355108, "ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00355108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*